Detailansicht

Wissensnetz

Person

Kristen Brennand

Biologin

Name	Kristen Brennand
Zeit	2007- (Wirkungsdaten)
Ort	USA
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Biologin (charakteristischer Beruf) Hochschullehrerin
Variante	K. J. Brennand
Beziehung	Yale University Icahn School of Medicine at Mount Sinai (New York)
Quelle	https://medicine.yale.edu/profile/kristen-brennand/ (Stand: 27.10.2023)
Datensatztyp	Person
GND-Nummer	1261155084
Datensatz-ID	1261155084
Beteiligt an alle anzeigen Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility Analysis framework and experimental design for evaluating synergy-driving gene expression Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia Massively parallel techniques for cataloguing the regulome of the human brain Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism A psychiatric disease-related circular RNA controls synaptic gene expression and cognition Synergistic effects of common schizophrenia risk variants Entrainment of Circadian Rhythms to Temperature Reveals Amplitude Deficits in Fibroblasts from Patients with Bipolar Disorder and Possible Links to Calcium Channels GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder Expression-based drug screening of neural progenitor cells from individuals with schizophrenia THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders New considerations for hiPSC-based models of neuropsychiatric disorders Mapping regulatory variants in hiPSC models Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1 Patient-derived hiPSC neurons with heterozygous CNTNAP2 deletions display altered neuronal gene expression and network activity In utero exposure to maternal smoking is associated with DNA methylation alterations and reduced neuronal content in the developing fetal brain Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Kristen Brennand

Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease

Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission

Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome

Modeling gene × environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression

A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility

Analysis framework and experimental design for evaluating synergy-driving gene expression

Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia

Massively parallel techniques for cataloguing the regulome of the human brain

Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism

A psychiatric disease-related circular RNA controls synaptic gene expression and cognition

Synergistic effects of common schizophrenia risk variants

Entrainment of Circadian Rhythms to Temperature Reveals Amplitude Deficits in Fibroblasts from Patients with Bipolar Disorder and Possible Links to Calcium Channels

GJA1 (connexin43) is a key regulator of Alzheimer’s disease pathogenesis

Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders

New considerations for hiPSC-based models of neuropsychiatric disorders

Mapping regulatory variants in hiPSC models

Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains

Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1

Patient-derived hiPSC neurons with heterozygous CNTNAP2 deletions display altered neuronal gene expression and network activity

In utero exposure to maternal smoking is associated with DNA methylation alterations and reduced neuronal content in the developing fetal brain

Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample